↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Stamatopoulos A.) "

Search: WFRF:(Stamatopoulos A.)

Result 1-10 of 125

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Collaboration, The n_TOF, et al. (author) Nuclear data activities at the n_TOF facility at CERN 2016 In: Eur. Phys. J. Plus. - : Springer Science and Business Media LLC. ; 131:10 Journal article (peer-reviewed)
2.	Alaggio, R, et al. (author) Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748 2023 In: Leukemia. - 1476-5551. ; 37:9, s. 1944-1951 Journal article (other academic/artistic)
3.	Chatzikonstantinou, T, et al. (author) COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study 2021 In: Leukemia. - : Springer Science and Business Media LLC. - 1476-5551 .- 0887-6924. ; 35:12, s. 3444-3454 Journal article (peer-reviewed)abstract Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to Coronavirus disease 2019 (COVID-19) due to age, disease, and treatment-related immunosuppression. We aimed to assess risk factors of outcome and elucidate the impact of CLL-directed treatments on the course of COVID-19. We conducted a retrospective, international study, collectively including 941 patients with CLL and confirmed COVID-19. Data from the beginning of the pandemic until March 16, 2021, were collected from 91 centers. The risk factors of case fatality rate (CFR), disease severity, and overall survival (OS) were investigated. OS analysis was restricted to patients with severe COVID-19 (definition: hospitalization with need of oxygen or admission into an intensive care unit). CFR in patients with severe COVID-19 was 38.4%. OS was inferior for patients in all treatment categories compared to untreated (p < 0.001). Untreated patients had a lower risk of death (HR = 0.54, 95% CI:0.41–0.72). The risk of death was higher for older patients and those suffering from cardiac failure (HR = 1.03, 95% CI:1.02–1.04; HR = 1.79, 95% CI:1.04–3.07, respectively). Age, CLL-directed treatment, and cardiac failure were significant risk factors of OS. Untreated patients had a better chance of survival than those on treatment or recently treated.
4.	Blanco, G., et al. (author) Chromosome 8 Abnormalities Are Associated With An Even Worse Outcome And Karyotype Complexity In Patients With Chronic Lymphocytic Leukemia And Tp53 Aberrations 2016 In: Haematologica. - 0390-6078 .- 1592-8721. ; 101, s. 229-230 Journal article (other academic/artistic)
5.	Agathangelidis, A., et al. (author) HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA : UNIQUENESS VERSUS EQUIVALENCE 2015 In: Haematologica. - 0390-6078 .- 1592-8721. ; 100, s. 47-48 Journal article (other academic/artistic)
6.	Agorastos, T, et al. (author) Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study 2019 In: Cancer prevention research (Philadelphia, Pa.). - 1940-6215. ; 12:10, s. 701-710 Journal article (peer-reviewed)
7.	Pavlova, S, et al. (author) Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10 % Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL 2023 In: BLOOD. - 0006-4971. ; 142 Conference paper (other academic/artistic)
8.	Baliakas, Panagiotis, et al. (author) Not All IGHV3-21 CLL Are Equal : Subset #2 Displays a Distinctive Clinicobiological Profile with Remarkable Similarities to Subset #169, its Close Immunogenetic Relative 2014 In: Haematologica. - 0390-6078 .- 1592-8721. ; 99:S1, s. 48-49 Journal article (other academic/artistic)
9.	Navarro, A, et al. (author) Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features 2012 In: Cancer research. - 1538-7445. ; 72:20, s. 5307-5316 Journal article (peer-reviewed)
10.	Baliakas, P, et al. (author) B CELL RECEPTOR STEREOTYPY MAKES A CLINICAL DIFFERENCE IN CLL: REVELATIONS FROM A MULTI-INSTITUTIONAL SERIES OF 4615 CASES 2013 In: HAEMATOLOGICA. - 0390-6078. ; 98, s. 218-219 Conference paper (other academic/artistic)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 125

Refine your search

Type of publication: journal article (99); conference paper (22); research review (3); other publication (1)

Type of content: peer-reviewed (68); other academic/artistic (57)

Author/Editor: Stamatopoulos, K (89); Ghia, P (57); Agathangelidis, A (39); Pospisilova, S (37); Davi, F (35); Anagnostopoulos, A (31); show more...; Rosenquist, R. (29); Davis, Z (27); Belessi, C (27); Scarfo, L (26); Oscier, D. (26); Hadzidimitriou, A (24); Stamatopoulos, Kosta ... (24); Rosenquist, Richard (21); Chatzidimitriou, A (21); Plevova, K. (19); Rossi, D (18); Campo, E (17); Darzentas, N (16); Chiorazzi, N (16); Langerak, AW (14); Stalika, E. (14); Gaidano, G. (14); Stilgenbauer, S. (14); Mansouri, L. (13); Mansouri, Larry (13); Giudicelli, V (13); Psomopoulos, F (13); Baliakas, Panagiotis (13); Minga, E. (12); Xochelli, A. (12); Sutton, Lesley-Ann (12); Sutton, LA (12); Sutton, L. A. (11); Panagiotidis, P. (11); Nguyen-Khac, F. (11); Juliusson, G (10); Smedby, KE (10); Rosenquist, Richard ... (10); Catherwood, M. (9); Schuh, A (9); Puiggros, A. (9); Kotaskova, J. (9); Delgado, J. (8); Vlachonikola, E (8); Ranghetti, P (8); Chatzouli, M. (8); Trentin, L. (8); Parker, H. (8); Athanasiadou, A. (8); show less...

University: Karolinska Institutet (83); Uppsala University (56); Lund University (4); Umeå University (3); Örebro University (1); Linköping University (1); show more...; Linnaeus University (1); RISE (1); show less...

Language: English (125)

Research subject (UKÄ/SCB): Medical and Health Sciences (47); Natural sciences (6); Engineering and Technology (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view